Matches in Wikidata for { <http://www.wikidata.org/entity/Q76511719> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q76511719 description "1963 թվականի օգոստոսի 1-ին հրատարակված գիտական հոդված" @default.
- Q76511719 description "artículu científicu espublizáu n'agostu de 1963" @default.
- Q76511719 description "im August 1963 veröffentlichter wissenschaftlicher Artikel" @default.
- Q76511719 description "scientific article published on 01 August 1963" @default.
- Q76511719 description "wetenschappelijk artikel" @default.
- Q76511719 description "наукова стаття, опублікована в серпні 1963" @default.
- Q76511719 name "CLINICAL EXPERIENCE WITH THE MONOAMINE OXIDASE INHIBITOR, DL-SERINE-N-ISOPROPYLHYDRAZIDE (RO 4-1038), IN THE TREATMENT OF HYPERTENSION" @default.
- Q76511719 name "CLINICAL EXPERIENCE WITH THE MONOAMINE OXIDASE INHIBITOR, DL-SERINE-N-ISOPROPYLHYDRAZIDE (RO 4-1038), IN THE TREATMENT OF HYPERTENSION" @default.
- Q76511719 type Item @default.
- Q76511719 label "CLINICAL EXPERIENCE WITH THE MONOAMINE OXIDASE INHIBITOR, DL-SERINE-N-ISOPROPYLHYDRAZIDE (RO 4-1038), IN THE TREATMENT OF HYPERTENSION" @default.
- Q76511719 label "CLINICAL EXPERIENCE WITH THE MONOAMINE OXIDASE INHIBITOR, DL-SERINE-N-ISOPROPYLHYDRAZIDE (RO 4-1038), IN THE TREATMENT OF HYPERTENSION" @default.
- Q76511719 prefLabel "CLINICAL EXPERIENCE WITH THE MONOAMINE OXIDASE INHIBITOR, DL-SERINE-N-ISOPROPYLHYDRAZIDE (RO 4-1038), IN THE TREATMENT OF HYPERTENSION" @default.
- Q76511719 prefLabel "CLINICAL EXPERIENCE WITH THE MONOAMINE OXIDASE INHIBITOR, DL-SERINE-N-ISOPROPYLHYDRAZIDE (RO 4-1038), IN THE TREATMENT OF HYPERTENSION" @default.
- Q76511719 P1433 Q76511719-F484C207-060A-449F-B48A-B86F442E5B37 @default.
- Q76511719 P1476 Q76511719-01C8D203-6A4A-44CE-9F37-A0C2E0E17EE7 @default.
- Q76511719 P2093 Q76511719-3AC54446-1E61-4112-850B-FC444AB99A00 @default.
- Q76511719 P2093 Q76511719-A240B38F-F01D-4ABE-9633-C6DA710E0A63 @default.
- Q76511719 P2093 Q76511719-B64B1706-F938-48F5-94C2-4D3D649916DC @default.
- Q76511719 P2093 Q76511719-B6AA2BC5-8EAB-4BA5-8D9E-0F95095A09E9 @default.
- Q76511719 P304 Q76511719-7ED40886-17C7-46B0-9ED7-66B9258EEFD9 @default.
- Q76511719 P31 Q76511719-0276DFEC-427A-49C6-B9A3-481BC39433EB @default.
- Q76511719 P356 Q76511719-DB94ADB4-5061-4CF5-AC33-719DB493217C @default.
- Q76511719 P407 Q76511719-2D44751D-6954-401F-AC89-2C48B73E332C @default.
- Q76511719 P478 Q76511719-C38C7564-0964-41C6-AFBC-CF68260E1596 @default.
- Q76511719 P577 Q76511719-86E1364F-3FDE-41A3-8954-8F8F11B425DE @default.
- Q76511719 P698 Q76511719-6176B303-978C-41F1-B04F-E84B1C55F2D1 @default.
- Q76511719 P356 0002-8703(63)90030-9 @default.
- Q76511719 P698 14051181 @default.
- Q76511719 P1433 Q2227156 @default.
- Q76511719 P1476 "CLINICAL EXPERIENCE WITH THE MONOAMINE OXIDASE INHIBITOR, DL-SERINE-N-ISOPROPYLHYDRAZIDE (RO 4-1038), IN THE TREATMENT OF HYPERTENSION" @default.
- Q76511719 P2093 "C R KLEEMAN" @default.
- Q76511719 P2093 "H C GONICK" @default.
- Q76511719 P2093 "M H MAXWELL" @default.
- Q76511719 P2093 "S I ROTH" @default.
- Q76511719 P304 "151-163" @default.
- Q76511719 P31 Q13442814 @default.
- Q76511719 P356 "10.1016/0002-8703(63)90030-9" @default.
- Q76511719 P407 Q1860 @default.
- Q76511719 P478 "66" @default.
- Q76511719 P577 "1963-08-01T00:00:00Z" @default.
- Q76511719 P698 "14051181" @default.